Sign in

CIK 0001281895

  • Non-accelerated filer
  • Smaller reporting company

ROCKET PHARMACEUTICALS, INC.

Sign in to watch
Ticker
RCKT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 646-440-9100
Business address
350 FIFTH AVENUE, SUITE 7530, NEW YORK, NY, 10118
Former names
INOTEK PHARMACEUTICALS CORP
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$411,605
in 5 filings

Net −$411,605. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 48 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-12-10 RTW INVESTMENTS, LP Director Purchase +247,720 $56.00 $13.9M 17,530,044
2020-10-05 Patel Kinnari Chief Operating Officer Grant or award · Restricted Stock Units +10,000 10,000
2020-09-08 Patel Kinnari Chief Operating Officer Grant or award · Stock Option (Right to Buy) +50,000 50,000
2020-08-03 Militello John Grant or award · Stock Option (Right to Buy) +18,000 18,000
2020-06-16 SOUTHWELL DAVID P Director Grant or award · Stock Option (Right to Buy) +20,000 20,000
2020-06-16 GRANADILLO PEDRO P Director Grant or award · Stock Option (Right to Buy) +20,000 20,000
2020-06-16 WONG RODERICK Director Grant or award · Stock Option (Right to Buy) +27,000 27,000
2020-06-16 Makker Gotham Director Grant or award · Stock Option (Right to Buy) +20,000 20,000
2020-06-16 Makker Gotham Director Grant or award · Stock Option (Right to Buy) +9,784 $12.16 $119K 9,784
2020-06-16 Makker Gotham Director Grant or award · Stock Option (Right to Buy) +3,206 $12.16 $39K 3,206
2020-06-16 Bjork Elisabeth Director Grant or award · Stock Option (Right to Buy) +20,000 20,000
2020-06-16 Yalamanchi Naveen Director Grant or award · Stock Option (Right to Buy) +20,000 20,000
2020-06-16 BOESS CARSTEN Director Grant or award · Stock Option (Right to Buy) +20,000 20,000
2020-04-20 Bjork Elisabeth Director Grant or award · Stock Option (Right to Buy) +40,000 40,000
2020-03-24 Shah Gaurav President & CEO Exercise or conversion +90,925 $0.43 $39K 1,061,642
2020-03-24 Shah Gaurav President & CEO Shares withheld for taxes −32,645 $13.78 $450K 1,028,997
2020-03-24 Shah Gaurav President & CEO Exercise or conversion · Stock Option (Right to Buy) −90,925 0
2020-03-18 Patel Kinnari Chief Operating Officer Purchase +1,000 $9.50 $10K 6,675
2020-02-25 Shah Gaurav President & CEO Exercise or conversion +290,000 $0.43 $126K 976,950
2020-02-25 Shah Gaurav President & CEO Shares withheld for taxes −6,233 $20.15 $126K 970,717

Page 24 of 27 · 538 trades